1-6 of 6
Mehmet Altan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Tolerability of Lete-cel in NSCLC—Reply

Free
Mehmet Altan, Gilberto Lopes, T. Jeroen N. Hiltermann, Ramaswamy Govindan, Liza C. Villaruz, Emiliano Calvo, Martin J. Edelman, Muhammad Furqan, Joel Neal, Enriqueta Felip, Jennifer W. Carlisle, John V. Heymach, Róisín Eilish O’Cearbhaill, Marjorie Zauderer, Michael Chisamore, Ellie Corigliano, Ioanna Eleftheriadou, Stefan Zajic, Ben Jenkins, Sophia Goodison, Sunil Suchindran, Natalia Ramos-Hernandez, Nidale Tarek, Adam J. Schoenfeld
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (9): 1810–1811.
https://doi.org/10.1158/1078-0432.CCR-25-0070
Published: 01 May 2025
View article titled, Safety and Tolerability of Lete-cel in NSCLC—Reply
Open the PDF for Safety and Tolerability of Lete-cel in NSCLC—Reply in another window
Journal Articles

Impact of Co-mutations and Transcriptional Signatures in Non–Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial

Open Access
Marcelo V. Negrao, Alvaro G. Paula, David Molkentine, Laura Hover, Monique Nilsson, Natalie Vokes, Lars Engstrom, Andrew Calinisan, David M. Briere, Laura Waters, Jill Hallin, Lixia Diao, Mehmet Altan, George R. Blumenschein, Ferdinandos Skoulidis, Jing Wang, Scott E. Kopetz, David S. Hong, Don L. Gibbons, Peter Olson, James G. Christensen, John V. Heymach
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (6): 1069–1081.
https://doi.org/10.1158/1078-0432.CCR-24-2310
Published: 17 March 2025
View article titled, Impact of Co-mutations and Transcriptional Signatures in Non–Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial
Open the PDF for Impact of Co-mutations and Transcriptional Signatures in Non–Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial in another window
Includes: Supplementary data
Journal Articles

Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer

Open Access
Mehmet Altan, Gilberto Lopes, T. Jeroen N. Hiltermann, Ramaswamy Govindan, Liza C. Villaruz, Emiliano Calvo, Martin J. Edelman, Muhammad Furqan, Joel Neal, Enriqueta Felip, Jennifer W. Carlisle, John V. Heymach, Róisín Eilish O’Cearbhaill, Marjorie Zauderer, Michael Chisamore, Ellie Corigliano, Ioanna Eleftheriadou, Stefan Zajic, Ben Jenkins, Sophia Goodison, Sunil Suchindran, Natalia Ramos-Hernandez, Nidale Tarek, Adam J. Schoenfeld
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (3): 529–542.
https://doi.org/10.1158/1078-0432.CCR-24-1591
Published: 03 February 2025
View article titled, Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer
Open the PDF for Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes

Free
Mehmet Altan, Vasiliki Pelekanou, Kurt A. Schalper, Maria Toki, Patricia Gaule, Konstantinos Syrigos, Roy S. Herbst, David L. Rimm
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (17): 5202–5209.
https://doi.org/10.1158/1078-0432.CCR-16-3107
Published: 31 August 2017
View article titled, B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes
Open the PDF for B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes in another window
Includes: Supplementary data
Journal Articles

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

Free
Kurt A. Schalper, Daniel Carvajal-Hausdorf, Joseph McLaughlin, Mehmet Altan, Vamsidhar Velcheti, Patricia Gaule, Miguel F. Sanmamed, Lieping Chen, Roy S. Herbst, David L. Rimm
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 370–378.
https://doi.org/10.1158/1078-0432.CCR-16-0150
Published: 15 January 2017
View article titled, Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer
Open the PDF for Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer

Free
Lajos Pusztai, Stacy Moulder, Mehmet Altan, Danielle Kwiatkowski, Vicente Valero, Naoto T. Ueno, Francisco J. Esteva, Rony Avritscher, Yuan Qi, Lewis Strauss, Gabriel N. Hortobagyi, Christos Hatzis, W. Fraser Symmans
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (20): 5265–5271.
https://doi.org/10.1158/1078-0432.CCR-14-0800
Published: 14 October 2014
View article titled, Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer
Open the PDF for Gene Signature–Guided Dasatinib Therapy in Metastatic Breast Cancer in another window
Includes: Supplementary data